Conversation with The Cancer LetterCOVID-19 & CancerFree Feist-Weiller mammography vans repurposed to screen for COVID-19 in northwest Louisiana April 24, 2020Vol.46 No.17By Alexandria Carolan
COVID-19 & CancerFreeGuest Editorial COVID-Lung Cancer Consortium:An example of how the lung cancer community came together in a challenging time April 24, 2020Vol.46 No.17By Fred R. Hirsch, Paul A. Bunn Jr and John D. Minna
COVID-19 & CancerFreeGuest Editorial When disparities widen: COVID-19 in minority patients with cancer April 24, 2020Vol.46 No.17By Coral Olazagasti and Narjust Florez
Conversation with The Cancer LetterCOVID-19 & CancerFree Berry: “Designing clinical trials doesn’t have high priority when there’s no pandemic. And then, when there’s a pandemic, there’s panic” April 24, 2020Vol.46 No.17By Matthew Bin Han Ong
COVID-19 & CancerFree Remdesivir, IL inhibitors emerge as frontrunners in race to treat COVID-19Phase III results for remdesivir expected within weeks April 24, 2020Vol.46 No.17By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree As COVID-19 peaks in San Antonio, Ruben Mesa predicts gradual reopening April 22, 2020Vol.46 No.17By Paul Goldberg
FreeIn Brief J. Alan Diehl named deputy director and chief operating officer of Case CCC April 17, 2020Vol.46 No.16
FreeIn Brief Esther Welkowsky named VP, clinical operations, at Elicio Therapeutics April 17, 2020Vol.46 No.16
